COMPLICATIONS OF INTRACAVITARY BACILLUS-CALMETTE-GUERIN AFTER PERCUTANEOUS RESECTION OF UPPER TRACT TRANSITIONAL-CELL CARCINOMA

被引：35
|
作者：
BELLMAN, GC
SWEETSER, P
SMITH, AD
机构：
[1] Department of Urology, Long Island Jewish Medical Center, New Hyde Park, NY
来源：
JOURNAL OF UROLOGY | 1994年 / 151卷 / 01期
关键词：
BCG VACCINE; KIDNEY NEOPLASMS; CARCINOMA; TRANSITIONAL CELL;
D O I：
10.1016/S0022-5347(17)34860-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Percutaneous resection and intracavitary instillation of bacillus Calmette-Guerin (BCG) is currently being used in treatment protocols in select patients in whom the standard nephroureterectomy for upper tract transitional cell carcinoma is undesirable. However, the complications of BCG in these patients are not well defined. Among 16 patients treated in this manner 4 (25%) had asymptomatic granulomatous involvement of the renal pelvis discovered during regular followup nephroscopy and biopsy: 2 had recurrent carcinoma at discovery, whereas the other 2 remain free of disease. The significance and therapeutic consequences of BCG granulomatosis are unknown. Continued followup is necessary to identify any complications of BCG therapy.
引用
收藏
页码：13 / 15
页数：3
相关论文
共 50 条
  • [1] Fever following intracavitary Bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma
    Schnapp, DS
    Weiss, GH
    Smith, AD
    [J]. JOURNAL OF UROLOGY, 1996, 156 (02): : 386 - 388
  • [2] INTRAVESICAL BACILLUS-CALMETTE-GUERIN FOR TREATMENT OF SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE PROSTATIC URETHRA IN ASSOCIATION WITH CARCINOMA OF THE BLADDER
    SCHELLHAMMER, PF
    LADAGA, LE
    MORIARTY, RP
    [J]. JOURNAL OF UROLOGY, 1995, 153 (01): : 53 - 56
  • [3] A 20-Year Experience With Percutaneous Resection of Upper Tract Transitional Carcinoma: Is There an Oncologic Benefit With Adjuvant Bacillus Calmette Guerin Therapy?
    Rastinehad, Ardeshir R.
    Ost, Michael C.
    VanderBrink, Brian A.
    Greenberg, Kathryn L.
    El-Hakim, Assaad
    Marcovich, Robert
    Badlani, Gopal H.
    Smith, Arthur D.
    [J]. UROLOGY, 2009, 73 (01) : 27 - 31
  • [4] Ureteroscopic resection of upper-tract transitional-cell carcinoma
    Ho, KLV
    Chow, GK
    [J]. JOURNAL OF ENDOUROLOGY, 2005, 19 (07) : 841 - 848
  • [5] PERCUTANEOUS MANAGEMENT OF UPPER-TRACT TRANSITIONAL-CELL CARCINOMA
    STREEM, SB
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1995, 22 (01) : 221 - 229
  • [6] Tract seeding after percutaneous resection of upper tract transitional cell carcinoma (UTTCC)
    Rastinehad, Ardeshir R.
    Ost, Michael C.
    Greenberg, Kathryn L.
    VanderBrink, Brian A.
    Okeke, Zeph
    Lee, Benjamin R.
    Smith, Arthur D.
    [J]. JOURNAL OF ENDOUROLOGY, 2007, 21 : A263 - A263
  • [7] Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract
    Nonomura, N
    Ono, Y
    Nozawa, M
    Fukui, T
    Harada, Y
    Nishimura, K
    Takaha, N
    Takahara, S
    Okuyama, A
    [J]. EUROPEAN UROLOGY, 2000, 38 (06) : 701 - 704
  • [8] A 20-Year Experience With Percutaneous Resection of Upper Tract Transitional Carcinoma: Is There an Oncologic Benefit With Adjuvant Bacillus Calmette Guerin Therapy? Editorial Comment
    Marshall, Fray F.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (01): : 97 - 97
  • [9] Ureteroscopic surgery for upper tract transitional-cell carcinoma: Complications and management
    Chen, GL
    Bagley, DH
    [J]. JOURNAL OF ENDOUROLOGY, 2001, 15 (04) : 399 - 404
  • [10] DEFINITIVE TUMOR RESECTION AND PERCUTANEOUS BACILLE CALMETTE-GUERIN FOR MANAGEMENT OF RENAL PELVIC TRANSITIONAL-CELL CARCINOMA IN SOLITARY KIDNEYS
    VASAVADA, SP
    STREEM, SB
    NOVICK, AC
    [J]. UROLOGY, 1995, 45 (03) : 381 - 386
12345